Szepesházi, K <br/><br/>
Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs.  [electronic resource] 

 -  Journal of cancer research and clinical oncology   
 - 444-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0171-5216 
<br/><br/><label>Standard No.: </label>10.1007/s004320050301  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Apoptosis--drug effects<br/>Bombesin--analogs & derivatives<br/>Cricetinae<br/>Disease Models, Animal<br/>Down-Regulation--drug effects<br/>ErbB Receptors--drug effects<br/>Estradiol--blood<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gonadotropin-Releasing Hormone--analogs & derivatives<br/>Growth Hormone--blood<br/>Luteinizing Hormone--blood<br/>Mesocricetus<br/>Mitotic Index--drug effects<br/>Nucleolus Organizer Region--drug effects<br/>Pancreatic Neoplasms--blood<br/>Peptide Fragments--therapeutic use<br/>Time Factors